Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Open in API
Filings indexed 339 across all filing types
Latest filing 2023-12-07 Report Publication Anno…
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Finansiell kalender
Report Publication Announcement Classification · 97% confidence The document is titled "Finansiell kalender" (Financial Calendar) and lists future dates for various corporate events such as Quarterly Reports (Kvartalsrapport), Half-Year Report (Halvårsrapport), Annual Report (Årsrapport), and Annual General Meeting (Ordinær generalforsamling). This document is not the report itself (like 10-K or IR), nor is it a specific announcement about a single event's outcome (like DVA or ER). It is a schedule of upcoming corporate disclosures and meetings. None of the specific filing codes (AGM-R, 10-K, ER, IR, etc.) perfectly match a 'Financial Calendar'. However, since it announces the timing of future reports and meetings, it functions as a general corporate update or regulatory disclosure regarding the company's schedule. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback category for a general, scheduled corporate announcement that doesn't fit the specific outcome-based categories. It is a mandatory disclosure of the financial schedule.
2023-12-07 Norwegian
Financial calendar
Report Publication Announcement Classification · 99% confidence The document is titled 'Financial calendar' and lists scheduled dates for future corporate events, specifically Quarterly Reports (Q1, Q3, Q4), Half-yearly Report, Annual Report, and the Annual General Meeting (AGM). It is not the report itself, but a schedule of upcoming publications. Since there is no specific category for a 'Financial Calendar', and it is an announcement about future corporate events/reports, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, although it is not a standard regulatory filing form. Given the options, RNS is the most appropriate fallback for a general schedule announcement.
2023-12-07 English
Inify Laboratories receives accreditation as a medical laboratory
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Inify Laboratories has received ISO 15189 accreditation for its medical laboratory services. It does not contain financial statements, board changes, or specific regulatory filings required by the other categories. As it is a general corporate announcement regarding operational milestones, it falls under the fallback category for regulatory announcements.
2023-11-06 English
Inify Laboratories har fått akkreditering som medisinsk laboratorium
Regulatory Filings Classification · 95% confidence The document is a press release dated November 6, 2023, announcing that Inify Laboratories has received accreditation as a medical laboratory according to the ISO 15189 standard from Swedac. This announcement details a significant operational milestone and market access achievement, including quotes from the CEO and CCO. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement regarding operational status and market positioning, and does not fit into the more specific categories like Director's Dealing (DIRS), Capital Change (CAP), or Dividend Notice (DIV), it falls best under the general 'Regulatory Filings' category as a miscellaneous regulatory/news announcement, or potentially a general 'Information' release. Given the options, 'RNS' (Regulatory Filings - general regulatory announcements and fallback) is the most appropriate classification for a press release detailing accreditation status, especially since it concludes with a statement about information disclosure obligations ('informasjonspliktig etter verdipapirhandelloven').
2023-11-06 English
Inify Laboratories erhåller ackreditering som medicinskt laboratorium
Regulatory Filings Classification · 95% confidence The document is a press release dated November 6, 2023, announcing that Inify Laboratories has received accreditation as a medical laboratory according to ISO 15189 standard from Swedac. This is an announcement regarding an operational milestone and regulatory compliance achievement, not a standard periodic financial report (like 10-K or IR), a management change (MANG), or a director's trade (DIRS). It is a specific operational update that doesn't fit neatly into the primary financial filing categories. Since it is a general regulatory/operational announcement that doesn't match other specific codes (like AGM-R, ER, CT, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it is an official public disclosure of a significant operational status change.
2023-11-06 Swedish
Inify Laboratories har fått akkreditering som medisinsk laboratorium
Regulatory Filings Classification · 100% confidence The document is a press release dated November 6, 2023, announcing that Inify Laboratories has received accreditation as a medical laboratory according to the ISO 15189 standard from Swedac. This type of announcement, detailing operational achievements, regulatory compliance milestones, or general corporate news that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report (like 10-K or IR), nor a specific management change (MANG) or director dealing (DIRS), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/corporate news announcements. The document length is short (3662 chars) and it is a direct announcement, not an announcement *of* a report.
2023-11-06 Norwegian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.